Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Efficacy and Safety of a Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Compared With its Components Given Alone: Results of a Phase 3, Open-Label, Randomised, 26-Week, Treat-to-Target Trial in Insulin-Naive Patients With Type 2 Diabetes
Johansson et al., 2005)
The primary outcome was AUD-related hospitalizations, which were analyzed using a Cox regression model with a within-individual design
In another study involving more than 96,000 patients initiating GLP-1s, 46% of patients with and 65% without Type 2 diabetes discontinued the drugs within one year
For best results, combine with regular physical activity and a low-fat diet
L-carnitine: more than just an alternative to glucose as an osmotic agent for peritoneal dialysis
US$ 26.37
US$ 24.51
US$ 24.52
